Author
Listed:
- Paolo Carrega
(Istituto G. Gaslini)
- Fabrizio Loiacono
(Istituto G. Gaslini)
- Emma Di Carlo
(‘G. d'Annunzio’ University
Centro di Scienze dell’Invecchiamento, Fondazione Università ‘G. d’Annunzio’)
- Angelo Scaramuccia
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro)
- Marco Mora
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro)
- Romana Conte
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro)
- Roberto Benelli
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro)
- Grazia Maria Spaggiari
(University of Genova)
- Claudia Cantoni
(Istituto G. Gaslini
University of Genova
Center of Excellence in Biomedical Research, Centro di Eccellenza per la Ricerca Biomedica (CEBR), University of Genova)
- Stefania Campana
(Laboratory of Immunology and Biotherapy, University of Messina)
- Irene Bonaccorsi
(Laboratory of Immunology and Biotherapy, University of Messina)
- Barbara Morandi
(University of Genova)
- Mauro Truini
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro)
- Maria Cristina Mingari
(Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino/IST-Istituto Nazionale per la Ricerca sul Cancro
University of Genova
Center of Excellence in Biomedical Research, Centro di Eccellenza per la Ricerca Biomedica (CEBR), University of Genova)
- Lorenzo Moretta
(IRCCS Bambino Gesù Children's Hospital)
- Guido Ferlazzo
(Laboratory of Immunology and Biotherapy, University of Messina
Cell Therapy Program, Azienda Ospedaliera Universitaria Policlinico ‘Gaetano Martino’)
Abstract
Tertiary lymphoid structures (TLSs) are a common finding in non-small cell lung cancer (NSCLC) and are predictors of favourable clinical outcome. Here we show that NCR+ innate lymphoid cell (ILC)-3 are present in the lymphoid infiltrate of human NSCLC and are mainly localized at the edge of tumour-associated TLSs. This intra-tumoral lymphocyte subset is endowed with lymphoid tissue-inducing properties and, on activation, produces IL-22, TNF-α, IL-8 and IL-2, and activates endothelial cells. Tumour NCR+ILC3 may interact with both lung tumour cells and tumour-associated fibroblasts, resulting in the release of cytokines primarily on engagement of the NKp44-activating receptor. In patients, NCR+ILC3 are present in significantly higher amounts in stage I/II NSCLC than in more advanced tumour stages and their presence correlate with the density of intratumoral TLSs. Our results indicate that NCR+ILC3 accumulate in human NSCLC tissue and might contribute to the formation of protective tumour-associated TLSs.
Suggested Citation
Paolo Carrega & Fabrizio Loiacono & Emma Di Carlo & Angelo Scaramuccia & Marco Mora & Romana Conte & Roberto Benelli & Grazia Maria Spaggiari & Claudia Cantoni & Stefania Campana & Irene Bonaccorsi & , 2015.
"NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures,"
Nature Communications, Nature, vol. 6(1), pages 1-13, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9280
DOI: 10.1038/ncomms9280
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9280. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.